A citation-based method for searching scientific literature

C Leland Rogers, Minhee Won, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, James Galvin, Shannon E Fogh, Emad Youssef, Nimisha Deb, Young Kwok, Clifford G Robinson, Hui-Kuo Shu, Barbara J Fisher, Valerie Panet-Raymond, William G McMillan, John F de Groot, Peixin Zhang, Minesh P Mehta. Int J Radiat Oncol Biol Phys 2020
Times Cited: 40







List of co-cited articles
322 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
67

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Leland Rogers, Peixin Zhang, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, James Galvin, David Brachman, Joseph M Jenrette,[...]. J Neurosurg 2018
103
67

EANO guidelines for the diagnosis and treatment of meningiomas.
Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D Jenkinson, Kita Sallabanda, Emmanuel Houdart, Andreas von Deimling, Pantelis Stavrinou, Florence Lefranc, Morten Lund-Johansen,[...]. Lancet Oncol 2016
368
47

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Felix Sahm, Daniel Schrimpf, Damian Stichel, David T W Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David E Reuss, David Capper,[...]. Lancet Oncol 2017
322
42


Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).
Damien C Weber, Carmen Ares, Salvador Villa, Saskia M Peerdeman, Laurette Renard, Brigitta G Baumert, Anna Lucas, Theo Veninga, Alessia Pica, Sarah Jefferies,[...]. Radiother Oncol 2018
64
37

Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
Leland Rogers, Igor Barani, Marc Chamberlain, Thomas J Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C Weber, Patrick Y Wen, Michael A Vogelbaum. J Neurosurg 2015
290
35

The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial.
Michael D Jenkinson, Mohsen Javadpour, Brian J Haylock, Bridget Young, Helen Gillard, Jacqui Vinten, Helen Bulbeck, Kumar Das, Michael Farrell, Seamus Looby,[...]. Trials 2015
101
30

Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Manish K Aghi, Bob S Carter, Garth R Cosgrove, Robert G Ojemann, Sepideh Amin-Hanjani, Robert L Martuza, William T Curry, Fred G Barker. Neurosurgery 2009
300
27

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Koray Ozduman, Timuçin Avşar, Jie Li, Phillip B Murray, Octavian Henegariu,[...]. Science 2013
474
25

The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection.
Douglas A Hardesty, Andrew B Wolf, David G Brachman, Heyoung L McBride, Emad Youssef, Peter Nakaji, Randall W Porter, Kris A Smith, Robert F Spetzler, Nader Sanai. J Neurosurg 2013
100
25

Adjuvant radiotherapy for atypical meningiomas.
Hilary P Bagshaw, Lindsay M Burt, Randy L Jensen, Gita Suneja, Cheryl A Palmer, William T Couldwell, Dennis C Shrieve. J Neurosurg 2017
53
22

An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas.
Sam Q Sun, Ammar H Hawasli, Jiayi Huang, Michael R Chicoine, Albert H Kim. Neurosurg Focus 2015
79
20

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Thomas J Kaley, Patrick Wen, David Schiff, Keith Ligon, Sam Haidar, Sasan Karimi, Andrew B Lassman, Craig P Nolan, Lisa M DeAngelis, Igor Gavrilovic,[...]. Neuro Oncol 2015
142
20

TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuss, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher,[...]. J Natl Cancer Inst 2015
185
20

Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection.
Sam Q Sun, Albert H Kim, Chunyu Cai, Rory K J Murphy, Todd DeWees, Peter Sylvester, Ralph G Dacey, Robert L Grubb, Keith M Rich, Gregory J Zipfel,[...]. Neurosurgery 2014
75
20

Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
Saman Moritz Hemmati, Pirus Ghadjar, Arne Grün, Harun Badakhshi, Sebastian Zschaeck, Carolin Senger, Güliz Acker, Martin Misch, Volker Budach, David Kaul. Radiat Oncol 2019
18
38

Radiotherapy for atypical meningiomas.
Richard Mair, Kevin Morris, Ian Scott, Thomas A Carroll. J Neurosurg 2011
119
17

Epidemiology and etiology of meningioma.
Joseph Wiemels, Margaret Wrensch, Elizabeth B Claus. J Neurooncol 2010
580
17

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.
Priscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, Robert T Jones, Aaron McKenna, Gad Getz, Keith L Ligon, Emanuele Palescandolo, Paul Van Hummelen, Matthew D Ducar,[...]. Nat Genet 2013
373
17

WHO grade II and III meningiomas: a study of prognostic factors.
Anne Durand, François Labrousse, Anne Jouvet, Luc Bauchet, Michel Kalamaridès, Philippe Menei, Robert Deruty, Jean Jacques Moreau, Michelle Fèvre-Montange, Jacques Guyotat. J Neurooncol 2009
200
15

Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.
Chenyang Wang, Tania B Kaprealian, John H Suh, Charlotte D Kubicky, Jeremy N Ciporen, Yiyi Chen, Jerry J Jaboin. Neuro Oncol 2017
53
15

Predictors of early progression of surgically treated atypical meningiomas.
Karol P Budohoski, James Clerkin, Christopher P Millward, Philip J O'Halloran, Mueez Waqar, Seamus Looby, Adam M H Young, Mathew R Guilfoyle, Diana Fitzroll, Abel Devadass,[...]. Acta Neurochir (Wien) 2018
32
18

Stereotactic radiosurgery for atypical and anaplastic meningiomas.
Hideyuki Kano, Jun A Takahashi, Takahisa Katsuki, Norio Araki, Natsuo Oya, Masahiro Hiraoka, Nobuo Hashimoto. J Neurooncol 2007
66
15

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review.
Thomas Kaley, Igor Barani, Marc Chamberlain, Michael McDermott, Katherine Panageas, Jeffrey Raizer, Leland Rogers, David Schiff, Michael Vogelbaum, Damien Weber,[...]. Neuro Oncol 2014
121
15

The effect of radiosurgery during management of aggressive meningiomas.
Anthony E Harris, John Y K Lee, Bennett Omalu, John C Flickinger, Douglas Kondziolka, L Dade Lunsford. Surg Neurol 2003
86
15

Atypical and anaplastic meningiomas treated with bevacizumab.
Lakshmi Nayak, Fabio M Iwamoto, Jeremy D Rudnick, Andrew D Norden, Eudocia Quant Lee, Jan Drappatz, Antonio Omuro, Thomas J Kaley. J Neurooncol 2012
109
15

Radiosurgery as definitive management of intracranial meningiomas.
Douglas Kondziolka, David Mathieu, L Dade Lunsford, Juan J Martin, Ricky Madhok, Ajay Niranjan, John C Flickinger. Neurosurgery 2008
258
15

An overview of meningiomas.
Robin A Buerki, Craig M Horbinski, Timothy Kruser, Peleg M Horowitz, Charles David James, Rimas V Lukas. Future Oncol 2018
111
15

Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Salah Hammouche, Simon Clark, Alex Hie Lin Wong, Paul Eldridge, Jibril Osman Farah. Acta Neurochir (Wien) 2014
90
15

Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.
Varun R Kshettry, Quinn T Ostrom, Carol Kruchko, Ossama Al-Mefty, Gene H Barnett, Jill S Barnholtz-Sloan. Neuro Oncol 2015
98
15

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas.
Philipp Sievers, Thomas Hielscher, Daniel Schrimpf, Damian Stichel, David E Reuss, Anna S Berghoff, Marian C Neidert, Hans-Georg Wirsching, Christian Mawrin, Ralf Ketter,[...]. Acta Neuropathol 2020
28
21

Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
Victoria E Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W Youngblood, Tong Ihn Lee, Jacob F Baranoski, A Gulhan Ercan-Sencicek, Brian J Abraham, Abraham S Weintraub, Denes Hnisz,[...]. Nat Genet 2016
166
15

Early adjuvant radiotherapy in the treatment of atypical meningioma.
Michael D Jenkinson, Mueez Waqar, Jibril Osman Farah, Michael Farrell, Giuseppe M V Barbagallo, Robin McManus, Seamus Looby, Deirdre Hussey, David Fitzpatrick, Francesco Certo,[...]. J Clin Neurosci 2016
45
12

Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria.
Blake E Pearson, James M Markert, Winfield S Fisher, Barton L Guthrie, John B Fiveash, Cheryl A Palmer, Kristen Riley. Neurosurg Focus 2008
126
12

Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Christopher S Graffeo, Heather E Leeper, Avital Perry, Joon H Uhm, Daniel J Lachance, Paul D Brown, Daniel J Ma, Jamie J Van Gompel, Caterina Giannini, Derek R Johnson,[...]. World Neurosurg 2017
35
14

Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.
Ayal A Aizer, Nils D Arvold, Paul Catalano, Elizabeth B Claus, Alexandra J Golby, Mark D Johnson, Ossama Al-Mefty, Patrick Y Wen, David A Reardon, Eudocia Q Lee,[...]. Neuro Oncol 2014
58
12

Epidemiology of intracranial meningioma.
Elizabeth B Claus, Melissa L Bondy, Joellen M Schildkraut, Joseph L Wiemels, Margaret Wrensch, Peter M Black. Neurosurgery 2005
341
12

Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
Gurvinder Kaur, Eli T Sayegh, Andrew Larson, Orin Bloch, Michelle Madden, Matthew Z Sun, Igor J Barani, C David James, Andrew T Parsa. Neuro Oncol 2014
121
12

Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.
David Pasquier, Stefan Bijmolt, Theo Veninga, Nicolas Rezvoy, Salvador Villa, Marco Krengli, Damien C Weber, Brigitta G Baumert, Emine Canyilmaz, Deniz Yalman,[...]. Int J Radiat Oncol Biol Phys 2008
149
12

Intracranial meningiomas of atypical (WHO grade II) histology.
Leland Rogers, Mark Gilbert, Michael A Vogelbaum. J Neurooncol 2010
104
12

A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma.
Kent C Shih, Sajeel Chowdhary, Paul Rosenblatt, Alva B Weir, Gregg C Shepard, Jeffrey T Williams, Mythili Shastry, Howard A Burris, John D Hainsworth. J Neurooncol 2016
49
12

Radiotherapy for atypical or malignant intracranial meningioma.
M F Milosevic, P J Frost, N J Laperriere, C S Wong, W J Simpson. Int J Radiat Oncol Biol Phys 1996
159
12

The role of radiotherapy following gross-total resection of atypical meningiomas.
Ricardo J Komotar, J Bryan Iorgulescu, Daniel M S Raper, Eric C Holland, Kathryn Beal, Mark H Bilsky, Cameron W Brennan, Viviane Tabar, Jonathan H Sherman, Yoshiya Yamada,[...]. J Neurosurg 2012
110
12

The role of adjuvant radiotherapy in atypical meningioma.
Hae Jin Park, Hyun-Cheol Kang, Il Han Kim, Sung-Hye Park, Dong Gyu Kim, Chul-Kee Park, Sun Ha Paek, Hee-Won Jung. J Neurooncol 2013
84
12

BAP1 mutations in high-grade meningioma: implications for patient care.
Ganesh M Shankar, Sandro Santagata. Neuro Oncol 2017
77
12

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.
Jeffrey J Raizer, Sean A Grimm, Alfred Rademaker, James P Chandler, Kenji Muro, Irene Helenowski, Laurie Rice, Katie McCarthy, Sandra K Johnston, Maciej M Mrugala,[...]. J Neurooncol 2014
61
12

Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.
Raymond Y Huang, Wenya Linda Bi, Michael Weller, Thomas Kaley, Jaishri Blakeley, Ian Dunn, Evanthia Galanis, Matthias Preusser, Michael McDermott, Leland Rogers,[...]. Neuro Oncol 2019
53
12

Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection.
Sam Q Sun, Chunyu Cai, Rory K J Murphy, Todd DeWees, Ralph G Dacey, Robert L Grubb, Keith M Rich, Gregory J Zipfel, Joshua L Dowling, Eric C Leuthardt,[...]. Neurosurgery 2014
62
12

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
Malak Abedalthagafi, Wenya Linda Bi, Ayal A Aizer, Parker H Merrill, Ryan Brewster, Pankaj K Agarwalla, Marc L Listewnik, Dora Dias-Santagata, Aaron R Thorner, Paul Van Hummelen,[...]. Neuro Oncol 2016
144
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.